Northwest Investment Counselors’s AstraZeneca AZN Stock Holding History

Northwest Investment Counselors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$76.2K	Buy	+489	New	+$78.9K	0.02%	204
2024 Q2	–	Sell	-161	Closed	-$21.8K	–	174
2024 Q1	$21.8K	Buy	+161	New	+$21.3K	0.01%	302
2023 Q4	–	Sell	-161	Closed	-$21.8K	–	168
2023 Q3	$21.8K	Hold	161	–	–	0.01%	300
2023 Q2	$23K	Hold	161	–	–	0.01%	306
2023 Q1	$22.4K	Hold	161	–	–	0.01%	316
2022 Q4	$21.8K	Hold	161	–	–	0.01%	323
2022 Q3	$18K	Sell	161 -48	-23%	-$6.09K	0.01%	310
2022 Q2	$28K	Hold	209	–	–	0.01%	273
2022 Q1	$28K	Buy	209 +48	+30%	+$5.76K	0.01%	285
2021 Q4	$19K	Buy	+161	New	+$18.9K	﹤0.01%	310
2021 Q2	–	Sell	-161	Closed	-$16K	–	170
2021 Q1	$16K	Buy	+161	New	+$16.2K	﹤0.01%	321
2020 Q4	–	Sell	-161	Closed	-$18K	–	165
2020 Q3	$18K	Buy	+161	New	+$17.9K	0.01%	277
2019 Q4	–	Sell	-161	Closed	-$14K	–	172
2019 Q3	$14K	Buy	+161	New	+$14K	0.01%	319

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwest Investment Counselors's AZN Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in AstraZeneca (AZN) in Q3 2024: 489 shares worth $76.2K. The stake represents 0.02% of the portfolio and ranks #204 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in AZN as recently as Q1 2024.

Northwest Investment Counselors first reported a position in AZN in Q3 2019 and has held it in 13 quarters since. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

Northwest Investment Counselors held 489 shares of AstraZeneca worth $76.2K as of Q3 2024.
AstraZeneca was a new Northwest Investment Counselors position in Q3 2024.
AstraZeneca made up 0.02% of Northwest Investment Counselors's portfolio in Q3 2024, its #204 holding.
Northwest Investment Counselors first reported a position in AstraZeneca in Q3 2019 and has held it in 13 quarters since.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.